US-health-virus-VACCINE-PFIZER

A view of the Food and Drug Administration's White Oak campus December 17, 2020, in Silver Spring, Maryland. - The US Food and Drug Administration (FDA) said it was working with Pfizer to revise a fact sheet for recipients of the Pfizer-BioNTech Covid-19 vaccine after two people had allergic reactions. The two people, both health workers, were vaccinated in Alaska and one of them had a serious or "anaphylactic" reaction resulting in hospitalization. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)
A view of the Food and Drug Administration's White Oak campus December 17, 2020, in Silver Spring, Maryland. - The US Food and Drug Administration (FDA) said it was working with Pfizer to revise a fact sheet for recipients of the Pfizer-BioNTech Covid-19 vaccine after two people had allergic reactions. The two people, both health workers, were vaccinated in Alaska and one of them had a serious or "anaphylactic" reaction resulting in hospitalization. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)
US-health-virus-VACCINE-PFIZER
BEPERKT MATERIAAL
Dit beeld kunt u niet online licentiëren. Neem contact met ons op als u dit beeld wilt licentiëren.

GEGEVENS

Beperkingen:
Neem voor gebruik voor alle commerciële of promotiedoeleinden contact op met uw lokale kantoor. Volledige redactionele rechten in het Verenigd Koninkrijk, de Verenigde Staten, Ierland, Italië, Spanje en Canada (behalve Québec). Beperkte redactionele rechten in andere delen van de wereld. Bel ons lokale kantoor voor meer informatie hierover.
Credits:
BRENDAN SMIALOWSKI / Contributor
Redactioneel nr.:
1230180931
Collectie:
AFP
Gemaakt op:
17 december 2020
Datum van uploaden:
Soort licentie:
Rights managed
Release-informatie:
Geen release. Meer informatie
Bron:
AFP
Barcode:
AFP
Naam materiaal:
AFP_8XC8C3
Max. bestandsgrootte:
4500 x 2998 px (38,10 x 25,38 cm) - 300 dpi - 3 MB